PIK3CA and cervical squamous cell carcinoma: In line with this hypothesis we proposed here, a supporting observation has been reported for cervical squamous cell carcinoma (CECC) [107], showing that patients with PIK3CA-E545K mutations showed a partial response to treatment with PD-1 inhibitors.